This page contains brief information about sotorasib and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
Use in Cancer
Sotorasib is approved to treat:
- Non-small cell lung cancer (NSCLC) that has spread and has a KRAS p.G12C mutation. It is used in adults who have received at least one other systemic therapy.
Sotorasib is also being studied in the treatment of other types of cancer.
More About Sotorasib
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Research Results and Related Resources
Clinical Trials Accepting Patients
Find Clinical Trials for Sotorasib - Check for trials from NCI's list of cancer clinical trials now accepting patients.